What is the analyst price target for FOLD?

The average Wall Street analyst price target for FOLD is $14.50. This implies a potential upside of 0.1% from current levels.

FOLD Stock Analysis: Buy, Sell, or Hold?

FOLD - Amicus Therapeutics, Inc

PHARMACEUTICAL PREPARATIONS

$14.49

0.03 (0.21%) ▲

5d: +0.21%

30d: +0.42%

90d: +1.51%

BUY

MODERATE Confidence

Protect Your FOLD Gains

Analysis Updated: Apr 24, 2026 12:00 AM ET

Earnings: May 13, 2026 0d

Get Alerted When FOLD Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.

100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading historical data...

💡

Bottom Line:
💡 BUY OPPORTUNITY: FOLD shows positive signals but monitor for confirmation. Market pricing in 1.5% decline. Moderate conviction.

See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

Adjust Growth Assumption: 25.0%

0% (Stagnation) 50% (Hyper Growth)

EST. PRICE IN 2031

$29.50

Based on 14.5% avg growth

INTRINSIC VALUE TODAY

$18.32

20.9% Margin of Safety

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.5x Exit PE.

View Full DCF Model

In-depth Analysis How we analyze

Valuation Analysis: FOLD is currently trading at $14.49, which is considered fair based on recent price action. The stock's valuation (Forward PE: 17.7) is in line with its historical norms (18.5). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, FOLD is in a strong uptrend. The price is currently testing key support at $14.45. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR

Company Quality Score 60/100 (HOLD)

Volume Confirmation UNKNOWN

Confidence Score 62.9%

Protect Your Profits

FOLD is technically overbought (RSI 70). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

All Signals

NEUTRAL: Price in fair range
NEUTRAL: Mixed technical signals (40/100)
NEUTRAL: Near Wall St target ($14.50)

Support & Resistance Levels

Support Level $14.45

Resistance Level $14.50

Current Trend Strong Uptrend

Technical data as of Apr 24, 2026

Fundamental Context

Forward P/E (Next Year Est.) 17.69

Wall Street Target $14.50 (+0.1%)

Revenue Growth (YoY) 23.7%

Earnings Growth (YoY) -95.5%

Profit Margin -4.3%

Valuation Discount vs History -1.5% cheaper

PE vs Historical 17.7 vs 18.5 FAIR

Market-Implied Price Targets If current PE multiple persists

Implied Growth (YoY): -1.5% (market-implied from PE analysis)

1-Year Target $14.27 (-2%)

2-Year Target $14.06 (-3%)

3-Year Target $13.85 (-4%)

3-Yr Target (if PE normalizes) (PE: 18→19) $14.48 (0%)

3-Year Scenarios Using analyst projected EPS growth

Bull: (PE: 20.6, Growth: 1028.0%) $56.96 (+293%)

Base: (SPY PE: 17.7, Growth: 1028.0%) $48.90 (+238%)

Bear: (PE: 15.0, Growth: 1028.0%) $41.57 (+187%)

💡 Upside Surprise Potential

If earnings stabilize (0% growth), PE could expand from 17.7 to 18.5

Stabilization Target: $15.15 (+4.6%)

PE Expansion Potential: +4.6%

Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit

bloggers & journalists: you are free to use our charts with attribution.

Last updated: June 23, 2026 4:14 PM ET
Data refreshes hourly during market hours. Next update: 5:14 PM

🔥 Top Stocks Breaking Out Now

Ticker	Score	Recommendation	Change %

See Full Scanner Results »

Technical Signals Check

Is FOLD showing a specific setup today?

RSI Divergence Check TTM Squeeze Check MACD Crossover Check Gamma Walls Check Unusual Activity Check

Insider Activity (6 Months)

Buys

Sells

Net

INSIDERS SELLING

Recent Transactions

Bradley L Campbell SELL 22500 shares 2026-03-02

Bradley L Campbell SELL 75000 shares 2026-01-20

View Insider Activity Scanner

Unlock Insider Activity

See real-time buying/selling by company executives for FOLD.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock	Analyst Consensus	Analyst Target	Tradestie Score
NTLA Intellia Therapeutics Inc	STRONG BUY 29 analysts	$27	56 HOLD
ONC BeiGene, Ltd.	STRONG BUY 24 analysts	$412	57 HOLD
ARGX argenx NV ADR	STRONG BUY 22 analysts	$1022	67 BUY
INSM Insmed Inc	STRONG BUY 21 analysts	$197	61 BUY
ACLX Arcellx Inc	STRONG BUY 18 analysts	$113	57 HOLD

NTLA Intellia Therapeu…

Advanced FOLD Option Strategies

Professional options setups generated by AI based on today's FOLD price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for FOLD

FOLD Technical Chart FOLD Price Prediction FOLD Earnings Date FOLD Investment Advisor FOLD Fair Price Analyzer FOLD Options Advisor FOLD Options Chain FOLD Options Analysis FOLD Competitors

Compare FOLD with Peers

FOLD vs PTCT
Which one to buy?

FOLD vs AGIO
Which one to buy?

FOLD vs HALO
Which one to buy?

FOLD vs RARE
Which one to buy?

FOLD vs ACAD
Which one to buy?

Create New Comparison View All Competitors

Tradestie